Grochowski C, Blicharska E, Baj J, Mierzwinska A, Brzozowska K, Forma A, et al. Serum iron, magnesium, copper, and manganese levels in alcoholism: a systematic review. Molecules. 2019;24(7):1361.
2.•• Edwards S, Vendruscolo LF, Gilpin NW, Wojnar M, Witkiewitz K. Alcohol and pain: a translational review of preclinical and clinical findings to inform future treatment sstrategies. Alcohol Clin Exp Res. 2020;44(2):368–83. This study provides a comprehensive review of both preclinical and clinical findings that are related to the alcohol abuse and the induction of chronic pain.
3.World Health Organization. Global status report on alcohol and health 2018. World Health Organization 2018; https://wwwwhoint/publications/i/item/global-status-report-on-alcohol-and-health-2018 Accessed 24 Jul 2020.
4.Zaridze D, Brennan P, Boreham J, Boroda A, Karpov R, Lazarev A, et al. Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths. Lancet. 2009;373:2201–14.
CAS PubMed PubMed Central Google Scholar
5.World Health Organization. Global status report on alcohol and health 2011. World Health Organization. 2011; https://wwwwhoint/substance_abuse/publications/alcohol_2011/en/ Accessed 34 Jul 2020.
6.Rocco A, Compare D, Angrisani D, Sanduzzi Zamparelli M, Nardone G. Alcoholic disease: liver and beyond. World J Gastroenterol. 2014;20(40):14652–9.
CAS PubMed PubMed Central Google Scholar
7.Ferraguti G, Pascale E, Lucarelli M. Alcohol addiction: a molecular biology perspective. Curr Med Chem. 2015;22(6):670–84.
8.Haas SL, Ye W, Löhr JM. Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutri Metabol Care. 2012;15(5):457–67.
9.Braillon A. Treatment of alcohol use disorders in patients with liver disease. J Hepatol. 2016;65(6):1270.
10.Harper KM, Knapp DJ, Criswell HE, Breese GR. Vasopressin and alcohol: a multifaceted relationship. Psychopharmacology. 2018;235(12):3363–79.
CAS PubMed PubMed Central Google Scholar
11.Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29(4):437–45.
12.Davis BC, Bajaj JS. Effects of alcohol on the brain in cirrhosis: beyond hepatic encephalopathy. Alcohol Clin Exp Res. 2018;42(4):660–7.
13.Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis. Jama. 2019;322(24):2422.
14.Li G, Zhu L, Cao Z, Wang J, Zhou F, Wang X, et al. A new participant in the pathogenesis of alcoholic gastritis: Pyroptosis. Cell Physiol Biochem. 2018;49(1):406–18.
15.Gardner JD, Mouton AJ. Alcohol effects on cardiac function. Comprehen Physiol. 2015;5(2):791–802.
16.Gallagher C, Hendriks JM, Elliott AD, Wong CX, Rangnekar G, Middeldorp ME, et al. Alcohol and incident atrial fibrillation - a systematic review and meta-analysis. Int J Cardiol. 2017;246:46–52.
17.Maisch B. Alcoholic cardiomyopathy. Herz. 2016;41(6):484–93.
CAS PubMed PubMed Central Google Scholar
18.Fernández-Sola J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients. 2020;12(2):572.
19.Petroni ML, Brodosi L, Marchignoli F, Musio A, Marchesini G. Moderate alcohol intake in non-alcoholic fatty liver disease: to drink or not to drink? Nutrients. 2019;11(12):3048.
20.Arranz S, Chiva-Blanch G, Valderas-Martínez P, Medina-Remón A, Lamuela-Raventós RM, Estruch R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients. 2012;4(7):759–81.
CAS PubMed PubMed Central Google Scholar
21.Cahill PA, Redmond EM. Alcohol and cardiovascular disease-modulation of vascular cell function. Nutrients. 2012;4(4):297–318.
PubMed PubMed Central Google Scholar
22.Kang YJ, Zhou Z. Zinc prevention and treatment of alcoholic liver disease. Mol Asp Med. 2005;26(4–5):391–404.
23.Zahr NM, Pfefferbaum A. Alcohol's effects on the brain: neuroimaging results in humans and animal models. Alcohol Res. 2017;38(2):183–06.
PubMed PubMed Central Google Scholar
24.Arts N, Walvoort S, Kessels R. Korsakoff's syndrome: a critical review. Neuropsychiatr Dis Treat. 2017;13:2875–90.
PubMed PubMed Central Google Scholar
25.Chakravorty S, Chaudhary NS, Brower KJ. Alcohol dependence and its relationship with insomnia and other sleep disorders. Alcohol Clin Exp Res. 2016;40(11):2271–82.
PubMed PubMed Central Google Scholar
26.Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11(1):9.
27.•• Fama R. Introduction to the special section on alcohol: Review of cognitive, emotional, and neural deficits and recovery with sustained abstinence and treatment. Neuropsychology. 2019;33(6):757–9. This article is of high importance since it provides a comprehensive review regarding the alterations within various systems that are induced by chronic alcohol consumption as well as possible treatment strategies.
28.Hammoud N, Jimenez-Shahed J. Chronic neurologic effects of alcohol. Clin Liver Dis. 2019;23(1):141–55.
29.Grochowski C, Blicharska E, Bogucki J, Proch J, Mierzwinska A, Baj J, et al. Increased aluminum content in certain brain structures is correlated with higher silicon concentration in alcoholic use disorder. Molecules. 2019;24(9):1721.
CAS PubMed Central Google Scholar
30.Schuckit MA. Alcohol-use disorders, Lancet. 2009;7;373(9662):492–501.
31.Monte SMDL, Kril JJ. Human alcohol-related neuropathology. Acta Neuropathol. 2013;127(1):71–90.
PubMed PubMed Central Google Scholar
32.Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997;62:310–8.
CAS PubMed PubMed Central Google Scholar
33.Hoffman E, Staff N, Kabat B, Robb J, St. Sauver J, Klein C. A population based assessment of polyneuropathy and associated disability. American Academy of Neurology, San Diego, CA. Neurology. 2015;84(16):1644–1651.
34.Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol. 2001;8:157–65.
35.Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. CONTINUUM: Lifelong Learn Neurol. 2014;20:1293–306.
36.Katona I, Weis J. Diseases of the peripheral nerves. Handbook of Clinical Neurology Neuropathology. 2018;453–74.
37.Cherry CL, Wadley AL, Kamerman PR. Diagnosing and treating HIV-associated sensory neuropathy: a global perspective. Pain Manag. 2016;6(2):191–9.
38.Straube R, Müller G, Voit-Bak K, Tselmin S, Julius U, Schatz U, et al. Metabolic and non-metabolic peripheral neuropathy: is there a place for therapeutic apheresis? Horm Metab Res. 2019;51(12):779–84.
39.Newton SC, Marshall S. Effects of anodyne treatment on local blood flow and cutaneous sensation of the foot in a patient with peripheral neuropathy secondary to acromegaly. Physiother Theory Pract. 2019;:1–8.
40.Ungprasert P, Matteson EL. Neurosarcoidosis. Rheum Dis Clin N Am. 2017;43(4):593–606.
41.Boysson HD, Guillevin L. Polyarteritis Nodosa neurologic manifestations. Neurol Clin. 2019;37(2):345–57.
42.Aggarwal D. Prevalence of autonomic neuropathy in patients of rheumatoid arthritis and its correlation with disease severity. J Clin Diagn Res. 2017;11(4):OC09–13.
PubMed PubMed Central Google Scholar
43.Suliga E, Kozieł D, Ciesla E, Rebak D, Głuszek-Osuch M, Głuszek S. Consumption of alcoholic beverages and the prevalence of metabolic syndrome and its components. Nutrients. 2019;11(11):2764.
CAS PubMed Central Google Scholar
44.Skórzyńska-Dziduszko KE, Kimber-Trojnar Ż, Patro-Małysza J, Olszewska A, Zaborowski T, Małecka-Massalska T. An interplay between obesity and inflammation in gestational diabetes mellitus. Curr Pharm Biotechnol. 2016;17:603–13.
45.Rudolph T, Farbu E. Hospital-referred polyneuropathies-causes, prevalences, clinical- and neurophysiological findings. Eur J Neurol. 2007;14:603–8.
46.Ho KWD, Rempe T, Jerath N, Antony A. Dorsal root ganglion stimulation as a potentially effective treatment for painful hereditary and idiopathic axonal polyneuropathy: a retrospective case series. Neuromodulation: Technol Neur Interf. 2019. https://doi.org/10.1111/ner.12924.
47.Bechakra M, Nieuwenhoff MD, Rosmalen JV, Groeneveld GJ, Huygen FJ, Zeeuw CID, et al. Pain-related changes in cutaneous innervation of patients suffering from bortezomib-induced, diabetic or chronic idiopathic axonal polyneuropathy. Brain Res. 1730;2020:146621.
48.Hanewinckel R, Ikram MA, Van Doorn PA. Peripheral neuropathies. Handb Clin Neurol. 2016;138:263–82.
49.Munukutla S, Pan G, Deshpande M, Thandavarayan RA, Krishnamurthy P, Palaniyandi SS. Alcohol toxicity in diabetes and its complications: a double trouble? Alcohol Clin Exp Res. 2016;40(4):686–97.
50.Sadowski A, Houck RC. Alcoholic neuropathy. [Updated 2020 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499856/.
51.Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012;73(3):348–62.
52.Noble JM, Weimer LH. Neurologic complications of alcoholism. Continuum (Minneap Minn). 2014;20:624–41.
53.Mukherjee S. Alcoholism and its effects on the central nervous system. Curr Neurovasc Res. 2013;10(3):256–62.
54.Mcintosh C, Chick J. Alcohol and the nervous system. J Neurol Neurosurg Psychiatry. 2004;75(3):16–21.
55.Monforte R, Estruch R, Valls-Solé J, Nicolás J, Villalta J, Urbano-Marquez A. Autonomic and peripheral neuropathies in patients with chronic alcoholism: a dose-related toxic effect of alcohol. Arch Neurol. 1995;52(1):45–51.
56.Behse F, Buchthal F. Alcoholic neuropathy: clinical, electrophysiological and biopsy findings. Ann Neurol. 1977;2:95–110.
57.Mellion M, Gilchrist JM, de la Monte S. Alcohol-related peripheral neuropathy: nutritional, toxic, or both? Muscle Nerve. 2011;43(3):309–16.
CAS PubMed PubMed Central Google Scholar
58.Baj J, Flieger W, Teresiński G, Buszewicz G, Sitarz E, Forma A, et al. Magnesium, calcium, potassium, sodium, phosphorus, selenium, zinc, and chromium levels in alcohol use disorder: a review. J Clin Med. 2020;9(6):1901.
留言 (0)